Mehiläinen Health Care Agreement
Read more
Stockholm3 test
The Stockholm3 test measures the risk of prostate cancer and provides a percentage estimate of the likelihood of cancer requiring treatment as well as further treatment instructions. The test is available at laboratories without a doctor's referral.
Customer service and booking
010 414 0200 (local network rate/mobile charge)
At Mehiläinen, a test usually requires a doctor's referral and is conducted as part of a broader health examination or on the recommendation of a specialist.
Visit Mehiläinen when you need comprehensive diagnostics and possibly follow-up treatments, especially if there is a suspicion of cancer or a need for more detailed monitoring.
Puhti is a company owned by Mehiläinen that offers a service for measuring and monitoring one's own health.
Visit Puhti when you want to quickly and easily check your PSA levels. You can order tests from Puhti's website without a doctor's referral. The sample collection is done at Mehiläinen's laboratory. Results are presented in a clear format in the Oma Puhti report. If needed, you can order Mehiläinen's doctor's consultation as a separate service after the tests.
Docrates Mehiläinen is a cancer hospital specialized in the diagnostics, treatment, and monitoring of cancer diseases. Docrates is a pioneer in private cancer hospitals across Europe and is unique in the Nordic countries.
At Docrates Mehiläinen Cancer Hospital, patients suffering from cancer receive personalized services under one roof throughout their treatment and monitoring period: the operations emphasize the individuality and immediacy of cancer treatments, quality, education, and research.
At Docrates Mehiläinen Cancer Hospital, the PSA test is usually performed as part of comprehensive diagnostics and monitoring of cancer diseases.
The Stockholm3 test at a glance
- A blood test that measures the risk of prostate cancer and the percentage probability of prostate cancer requiring treatment.
- The Stockholm3 test involves taking a blood sample and collecting background information, which only takes a few minutes. The test does not require any special preparation and can be performed at any time of the day.
- The Stockholm3 test has been shown to reduce false suspicions of prostate cancer, while identifying more cancers that require treatment than the traditional PSA test.
What does the Stockholm3 test indicate?
For the Stockholm3 test, a blood sample is taken and you are asked for background information. The test result indicates the percentage probability of prostate cancer requiring treatment, in addition to which instructions for further treatment are provided.
- The blood sample is analysed to determine the level of PSA (prostate-specific antigen), which is a protein produced by prostate cells: if the value is more than 1.5 ug/l, additional protein markers and more than 100 gene complexes will be analysed.
- The results are combined with clinical background information: age, prostate medication, previous biopsies and a family history of prostate cancer.
- The test result indicates the percentage probability of prostate cancer requiring treatment and the corresponding recommended further actions.
- If the risk of prostate cancer is normal or lower than normal, a new blood sample is recommended to be taken within 2–6 years.
The test has been shown to reduce false suspicions of prostate cancer, while identifying more cancers that require treatment than the current clinical practice.
Who is the test suitable for?
The Stockholm3 test is primarily recommended for men aged 50–70 years. The test is also suitable for men aged between 45 and 50 years if they have a family history of prostate cancer or have a genetic predisposition to prostate cancer. The test is also recommended for men aged 70–75 if the risk of prostate cancer has previously been found to be increased and the person is in a good condition considering their age. Based on a doctor's assessment, men of other ages can also take the test.
If you want to be tested but are unsure whether the test is suitable for you, you should discuss this with your doctor.
How do I prepare for and book the Stockholm3 test?
You can request a Stockholm3 test at any Mehiläinen laboratory. You can book an appointment for a sample collection easily in Mehiläinen’s online appointment booking service or by calling Mehiläinen’s customer service at +358 (0)10 414 00 (local network rate/mobile charge). You can book a sample collection appointment at any Mehiläinen laboratory.
If you wish, you can also get the Stockholm3 test without a doctor's referral. If you are in doubt about what to do in your case, we recommend that you contact our customer service.
The Stockholm3 test does not require any special preparation, such as fasting. The test is a blood test that can be taken at any time of the day.
The sample collection includes the collection of a blood sample as well as the results and recommendations on further actions. The prices of further actions will be determined in accordance with the recommendations made separately.
The results of the laboratory test and recommendations on further actions are recorded in OmaMehiläinen. The results are usually available within a few days of the sample collection.
Further examinations include a retest after 2–6 years, ultrasound and palpation of the prostate or magnetic resonance imaging of the prostate and biopsies. Mehiläinen uses a high-quality magnetic resonance imaging (MRI) method in combination with the Stockholm3 test.
Even if your risk of prostate cancer based on the Stockholm3 test is higher than usual, accurate MRI can help to avoid biopsies. If the biopsies are taken, it will be easier to align them with high-quality images and fewer biopsies will need to be taken.
Take into account in the price list
No Kanta or outpatient clinic fees are added to the price of laboratory tests. The price is not affected by the time (evening or weekend), and no separate fee is charged for tests that need to be analyzed urgently.| Service | Price |
|---|---|
| Extended basic allergy screening and analysis test panel The test panel includes the basic screening and analysis of dust, pollen, dander and food groups. The dust, pollen and dander screening panel includes allergy tests for birch, timothy grass, mugwort, cat, dog, horse, outdoor mould and dust mites. The food screening covers egg whites, milk, wheat, cod, soy and peanuts. | 204,70 € No Kela reimbursement |
| Prostate test Stockholm3 (Pt-Sthlm3) The Stockholm3 test includes the collection and analysis of blood samples at the Mehiläinen location of your choice as well as the delivery of the results. Book an appointment for the test | 383,20 € No Kela reimbursement |
| Pharmacogenetic panel laboratory test The package covers 29 gene tests: ABCB1, ABCG2, ALDH2, BCHE, CACNA1S, CYP1A2, CYP2B6, CYP2C_rs12777823, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP4F2, DPYD, F2, F5, G6PD, GRIK4, IFNL3, MTHFR, NAT2, NFIB, NUDT15, SLCO1B1, TPMT, UGT1A1 and VKORC1. | 389,00 € No Kela reimbursement |
| Huoleton health check Huoleton health checkup includes laboratory tests, a nurse's appointment and a personal plan. | 169,00 € No Kela reimbursement |
| Liver function The package covers: B-PVK+T, P-GT, P-ALAT, P-Bil, S-CDT, P-TT, total cholesterol, HDL, Non-HDL, LDL and triglycerides. | 312,20 € No Kela reimbursement |
| Metabolic syndrome The package covers: fP-Gluk, U-Alb/krea, P-Uraat, P-ALAT, fS-LipoA1, fS-LipoB, fS-ApoB/A1, total cholesterol, HDL, Non-HDL, LDL and triglycerides. | 333,20 € No Kela reimbursement |
| Health examination for men over 50 The health examination includes a comprehensive laboratory package. Read more (in Finnish). | 249,00 € No Kela reimbursement |
| Health examination for women over 50 The health examination includes a comprehensive laboratory package. Read more (in Finnish). | 239,00 € No Kela reimbursement |
| The nut screening and components test package The test package covers the IgE antibodies of five varieties of nuts (peanut, hazelnut, walnut, Brazil nut and cashew). | 143,90 € No Kela reimbursement |
| Food group, diff. count and components test package The test package covers the IgE antibodies of the most common allergens causing food allergies (egg white, dairy, wheat, cod, soy and peanuts). | 143,90 € No Kela reimbursement |
| STD package 1 Includes the following tests: Chlamydia and gonorrhea (U-CtGcNhO), HIV (S-HIVAgAb) and syphilis (S-TrpaAb). | 242,40 € No Kela reimbursement |
| STD package 2 Includes the following tests: Chlamydia and gonorrhea (U-CtGcNhO), HIV (S-HIVAgAb), syphilis (S-TrpaAb), hepatitis B (S-HBsAg) and hepatitis C (S-HCVAb). | 415,60 € No Kela reimbursement |
| Cardiac and diabetes risk test Hertta (Pt-Cert) Learn more about the Hertta risk test. Book an appointment | 182,30 € No Kela reimbursement |
| Athlete's laboratory package The package covers: basic blood count (PVKT), ferritin to measure iron stores and resting electrocardiogram (ECG). | 165,50 € No Kela reimbursement |
| Blood Pressure & Heart laboratory package Includes the following tests: basic blood count (PVKT), blood fat values (total cholesterol, LDL and HDL cholesterol, triglycerides), apolipoproteins (ApoB and ApoA1), sensitive CRP (hS-CRP), long-term blood sugar (HbA1c), alanine aminotransferase (ALT) , sodium (Na), potassium (K), creatinine (Krea), thyroid test (TSH), urine chemical screening (U-kemSeula), and resting heart film (EKG). | 575,20 € No Kela reimbursement |
Other related services
Frequently asked questions about the Stockholm3 test
Prostate cancer is the most common cancer among men. More than 5,000 cases of prostate cancer are diagnosed annually in Finland.
The risk of cancer has previously been assessed mainly with the PSA test from a blood sample, followed by an ultrasound scan or other imaging examinations. In addition to the PSA test, an adequate diagnosis often requires biopsies.
The Stockholm3 test developed at the Karolinska Institute in Stockholm has been shown to reduce the need for MRI or biopsies by at least one third as the test result is more accurate than the PSA test value. Prostate cancers requiring treatment are detected by the Stockholm3 test at the same level or more than by the PSA test. The Stockholm3 test helps to minimise unnecessary suspicions of prostate cancer and, on the other hand, to detect cancer reliably at an earlier stage.
The method was initially tested in Finland in the joint Fin3 research project of Mehiläinen and Karolinska Institutet, and the test was gradually introduced for wider use.
Since PSA values may also be elevated in the absence of cancer, biopsies of the prostate are sometimes taken unnecessarily. The sample collection is not risk-free and the procedure involves discomfort and additional costs. On the other hand, not all cancers can be detected in time with the help of the PSA value result, as the person may have cancer even if the PSA is normal or only slightly elevated. In other words, two men can have the same PSA level, but one will have cancer and the other will not.
Our research partners:
